4DMedical Limited (ASX:4DX)

Market Cap	135.13M
Revenue (ttm)	5.86M
Net Income (ttm)	-39.54M
Shares Out	450.42M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550,107
Average Volume	1,259,223
Open	0.3000
Previous Close	0.3000
Day's Range	0.2850 - 0.3100
52-Week Range	0.2250 - 0.7150
Beta	1.36
RSI	51.18
Earnings Date	May 28, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 145
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DX

Financial Performance

In 2024, 4DMedical's revenue was 3.75 million, an increase of 422.45% compared to the previous year's 718,581. Losses were -35.98 million, 14.4% more than in 2023.